Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878214 · ClinicalTrials.gov registry record · NA
Promoting Smoking Cessation in Carpenters
A NA study of Cancer and Smoking Cessation, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
- 1
- Study location
NCT01878214: Completed NA study of Cancer and Smoking Cessation, sponsored by Washington University School of Medicine.
NCT01878214 is a NA study of Cancer and Smoking Cessation that has completed, run by Washington University School of Medicine. The registered enrollment target is 442 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01878214, a NA study of Cancer and Smoking Cessation, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test an innovative and sustainable intervention to increase participation in a union-sponsored smoking cessation program among carpenters and floor layers. The investigators will conduct a randomized controlled trial comparing targeted messaging versus standard messaging. All subjects will receive information about the free, union-sponsored smoking cessation program. Subjects randomized to the intervention group will receive additional targeted materials to encourage enrollment in the union's smoking cessation program. The intervention will include monthly mailed and text messages. The investigators hypothesize that subjects who receive targeted messages will be more likely to enroll in the union-sponsored smoking cessation program, be more likely to show change in readiness to quit smoking, and be more likely to quit smoking compared to subjects who receive only standard messaging.
Primary Outcome
Enrollment records from the union-sponsored smoking cessation program
Conditions Studied
Interventions
- BEHAVIORAL Targeted messaging
- BEHAVIORAL Standard messaging
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT01878214 record still lists
NCT01878214 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Targeted messaging is the first listed.
NCT01878214 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01878214 about?
NCT01878214 is a clinical study titled "Promoting Smoking Cessation in Carpenters". The purpose of this study is to test an innovative and sustainable intervention to increase participation in a union-sponsored smoking cessation program among carpenters and floor layers. The investigators will conduct a randomized controlled trial comparing targeted messaging versus standard messag...
What is the current status of trial NCT01878214?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2012-04. Estimated completion is 2014-03.
What conditions does trial NCT01878214 study?
This clinical trial studies the following conditions: Cancer, Smoking Cessation, Health Behavior.
What interventions are being tested in trial NCT01878214?
The interventions under investigation include: Targeted messaging (BEHAVIORAL), Standard messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT01878214?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01878214 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01878214's enrollment target sits among peer trials
442 142nd of 615 higher than 474 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia